4
Changes in Ownership
ALNYLAM PHARMACEUTICALS, INC. Filed Acc 0001735276-25-000002
Director sold 11,250 shares at $275.00 ($3,093,750)
- Director acquired 11,250 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
SHARP PHILLIP A · Director
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2025-01-23 | Exercise or conversion : show line 1 in the form 10b5-1 | +11,250 | $131.21 | $1,476,113 | 11,250 | D |
| 2025-01-23 | Sale : show line 2 in the form 10b5-1 | −11,250 | $275.00 | $3,093,750 | 0 | D |
| Open-market sales · 11,250 sh · avg $275.00 · $3,093,750 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2025-01-23 | Exercise or conversion : show line 3 in the form 10b5-1 Stock Option (right to buy) | −11,250 | 0 | D |
Loading xslF345X05/edgardoc.xml…